MetasTx, LLC

About MetasTx, LLC

MetasTx is a biotechnology company focused on creating novel therapeutics to treat and prevent the metastasis of cancer, particularly prostate cancer, without the severe side effects of current therapies like Androgen deprivation. Their mission is to improve patient survival and quality of life through innovative cancer treatments.

Products & Services

MTX-101:A novel cancer agent targeting solid tumors, specifically prostate cancer, with superior stability and efficacy in inhibiting tumor growth and metastasis, based on the delivery of IPA-3, a selective inhibitor of Group-1 P21 activated kinases (PAK).

Pipeline of Novel Cancer Agents:A range of treatments under development targeting specific solid tumors, leveraging advances in PAK-1 inhibition for cancers such as prostate, breast, and skin cancers.

Specialties

Cancer Metastasis Treatment Prostate Cancer Therapy PAK-1 Inhibition Solid Tumor Cancer Agents Epithelial-to-Mesenchymal Transition (EMT) Regulation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Pre-Seed Convertible Note T: - FT: Pre-Seed Convertible Note	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2025-06-25 FD: 2025-06-25	-

Pre-Seed Convertible Note Latest

2025-06-25

$500K

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Harvey D. Homan

Chief Executive Officer, Co-Founder

LinkedIn (Pro only)

S

Somanath Shenoy

Co-Founder

LinkedIn (Pro only)

J

Jackson (Jay) Gibbs

Head of Biology

D

David Crich

Head of Chemistry

B

Brian Cain

Board Member, Strategic Growth Advisor

S

Sandip Prasad

Urologic Oncologist

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

MetasTx, LLC Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised